KRISTEN MCINTYRE: Open Payments
NPI 1437824281 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 33 payments from 12 companies in 2025. Trend: 2023 $1,135 · 2024 $736 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $128 |
| ABBVIE INC. | 5 | $95 |
| PFIZER INC. | 5 | $91 |
| Lilly USA, LLC | 4 | $68 |
| Janssen Biotech, Inc. | 3 | $61 |
| Madrigal Pharmaceuticals | 2 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: Wegovy, NURTEC ODT, TREMFYA, REZDIFFRA, SKYRIZI, Ozempic, MOUNJARO, RINVOQ.
Industry payments across FL — which companies pay providers there.
